Fredun Pharma (539730)
FAST GROWERScore breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹827.85 |
| Market Cap | ₹397.59 Cr |
| P/E Ratio | 25.6 |
| ROCE | 18.94% |
| ROE | 26.02% |
| Dividend Yield | 0.04% |
| Profit Growth | 96.62% |
| Debt/Equity | — |
| Sales Growth | 56.7% |
| 52-Week Range | ₹745.05 — ₹2,620 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹256.63 |
Fredun Pharma trades with a P/E ratio of 25.6, ROCE of 18.94%, ROE of 26.02%, profit growth of 96.62%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer